- ICH GCP
- US Clinical Trials Registry
- Clinical Trial NCT01429428
Far-IR Emitted by Compression Stockings for Cellulitis Treatment
Randomized and Controlled Study About Efficacy and Safety of Far-Infra Red Radiation Emitted by Compression Stockings for Cellulitis Treatment
This is a randomized and controlled study to investigate if the far-IR radiation emitted by compression stockings fabric may be effective and safe as adjuvant treatment for cellulitis that affects the majority of women after puberty.
The investigators expect that the far-IR effects on superficial microcirculation,deep dermis and subcutaneous fat may attenuate the clinical aspect of cellulitis.
Study Overview
Status
Conditions
Intervention / Treatment
Detailed Description
Cellulitis is a sex-specific, anatomic and normal condition affecting women after puberty.The main clinical aspect is the irregularity on skin surface which is classified in 4 grades, 0 to III, according to Nurenberg classification, 1978.
It is a multifactorial condition, involving: herniation of subcutaneous fat into deep dermis; vertical fibrous septum from fatty tissue to dermis; alterations in microcirculation; hormonal and inflammatory factors Clinical evaluation is very difficult and the best methods are: high resolution ultrasound and magnetic resonance.
There is no effective management. Many devices have been introduced to treat that aesthetic condition which causes a great discomfort to women. There are few controlled studies with high level methodology and consistent conclusions.
The far-IR radiation can be obtained by low energy emitting devices and its main effects are the interaction with water and temperature increase. This method had already shown efficacy for circulation system disorders and wound healing by activation of TGF-beta and fibroblasts.
Our aim is to evaluate the benefits of far-IR for cellulitis control.
Study Type
Enrollment (Actual)
Phase
- Not Applicable
Participation Criteria
Eligibility Criteria
Ages Eligible for Study
Accepts Healthy Volunteers
Genders Eligible for Study
Description
Inclusion Criteria:
- Signed Consent Form
- Healthy women
- Age: 25 to 40 years
- Presence of cellulitis - II or III
- No treatment for cellulitis in the last 6 months
Exclusion Criteria:
- Pregnancy
- Vascular disease
- Psychiatric disorder
Study Plan
How is the study designed?
Design Details
- Primary Purpose: Treatment
- Allocation: Randomized
- Interventional Model: Single Group Assignment
- Masking: Quadruple
Arms and Interventions
Participant Group / Arm |
Intervention / Treatment |
|---|---|
|
Placebo Comparator: Stockings side one
This side of the compression stockings is just the fabric (placebo).
|
This side of compression stocking without far-IR radiation will be used by subjects, during the day, for six hours a day, during 90 days.
|
|
Active Comparator: Stocking side two
This side of compression stocking emits far-IR radiation.
|
The far-IR side of compression stocking will be used by subjects, during the day, for six hours a day, during 90 days.
|
What is the study measuring?
Primary Outcome Measures
Outcome Measure |
Measure Description |
Time Frame |
|---|---|---|
|
Changes in ultra-sound images
Time Frame: 0, 30, 60 and 90 days
|
High resolution ultra-sound (DemaScan, Cortex Technology, Denmark)is used to measure dermis density and thickness and distance between dermis and fatty tissue in the most evident two areas with cellulitis(thighs and buttocks)
|
0, 30, 60 and 90 days
|
Secondary Outcome Measures
Outcome Measure |
Measure Description |
Time Frame |
|---|---|---|
|
Changes in Cellulitis clinical grade
Time Frame: 0, 30, 60 and 90 days
|
Main investigator evaluates the clinical aspect of cellulitis, i.e., the level of irregularity of skin surface, according to Nuremberg and Müller classification in four grades: 0: no alterations I: alterations only visible by pinching the skin or contracting the muscles II: skin orange or padded aspect is visible when the woman stands up or by pinching the skin or contracting the muscles III: the same alterations of II associated to skin elevations and nodulations |
0, 30, 60 and 90 days
|
|
Subject evaluation
Time Frame: day 90th
|
Study subjects will give their opinion about modification on cellulitis appearance using a 5-point scale: much worse; worse; no change; better; much better
|
day 90th
|
|
Changes in Anthropometric measures
Time Frame: 0, 30, 60 and 90 days
|
The circumference of thighs, hip and waist are measured in standardized points
|
0, 30, 60 and 90 days
|
|
Changes in Photographies
Time Frame: 0, 30, 60 and 90 days
|
By using the OMNIA device standardized photos are taken in three positions: front buttocks and side view of thighs
|
0, 30, 60 and 90 days
|
|
Changes in Skin viscoelasticity
Time Frame: 0, 30, 60 and 90 days
|
Skin elasticity is measured by suction with the Cutometer device(Courage&Khazaka, Germany) in the most evident two areas with cellulitis(thighs and buttocks)
|
0, 30, 60 and 90 days
|
|
Changes in DLQI scores
Time Frame: 0 and 90 days
|
The application of the quality of life generic questionnaire named Dermatology Life Quality Index or DLQI(Finlay, 1994), version DLQI-Brasil (Ferraz, 2006) will be used to evaluate the impact of cellulitis and its treatment on women´s life
|
0 and 90 days
|
|
Occurence of adverse events
Time Frame: 30, 60 and 90 days
|
Report and/or observation of side effects,such as discomfort, difficulty to use the stockings or any distress will be registered
|
30, 60 and 90 days
|
|
Occurence of venous insufficiency signs
Time Frame: 30, 60 and 90 days
|
Symptoms and signals of venous insufficiency such as fatigue, swelling, burning will be evaluate by a five-point scale:0=none; 1 = slight; 2 = slight to moderate; 3 = moderate to severe; 4 = severe; 5 = unbearable
|
30, 60 and 90 days
|
|
Changes in Colour eco-doppler
Time Frame: 0 and 90 days
|
Superficial and deep venous systems will be evaluate before and at the end of the study by colour eco-doppler
|
0 and 90 days
|
Collaborators and Investigators
Sponsor
Investigators
- Principal Investigator: Edileia Bagatin, M.D., PhD, Universidade Federal de Sao Paulo, Brasil
Study record dates
Study Major Dates
Study Start
Primary Completion (Anticipated)
Study Completion (Anticipated)
Study Registration Dates
First Submitted
First Submitted That Met QC Criteria
First Posted (Estimate)
Study Record Updates
Last Update Posted (Estimate)
Last Update Submitted That Met QC Criteria
Last Verified
More Information
Terms related to this study
Additional Relevant MeSH Terms
Other Study ID Numbers
- SIGVARIS
- SigvarisUnifesp (Other Grant/Funding Number: Sigvaris do Brasil)
This information was retrieved directly from the website clinicaltrials.gov without any changes. If you have any requests to change, remove or update your study details, please contact register@clinicaltrials.gov. As soon as a change is implemented on clinicaltrials.gov, this will be updated automatically on our website as well.
Clinical Trials on Quality of Life
-
Ziekenhuis Oost-LimburgRecruitingQuality of Life | Postoperative Quality of Recovery | Health-Related Quality-of-LifeBelgium
-
Istituto Ortopedico RizzoliUniversity of BolognaCompletedImprove Quality of LifeItaly
-
Children's National Research InstituteCompletedProfessional Quality of LifeUnited States
-
Assiut UniversityUnknownImproving Quality of LifeEgypt
-
B. Braun Medical SAUnknownQuality of Life of Colostomized Patient
-
Mattu UniversityCompletedBreif Description: Patients' Quality of Life ofEthiopia
-
Linkoeping UniversityRecruiting
-
South Valley UniversityActive, not recruitingDeterminants of Health-related Quality of Life for Patients After Renal Lithotripsy: PNL Versus RIRSHealth Related Quality of LifeEgypt
-
University of South CarolinaNational Institute on Minority Health and Health Disparities (NIMHD)RecruitingHealth Related Quality of LifeUnited States
-
PharmanexSprim Advanced Life SciencesCompletedHealth-related Quality of LifeUnited States
Clinical Trials on No far-IR compression stockings
-
Imperial College LondonNational Institute for Health Research, United KingdomRecruitingSurgery | Venous ThromboembolismUnited Kingdom
-
University of WashingtonLake Washington Vascular; Sigvaris, IncUnknownVaricose VeinsUnited States
-
Imperial College LondonCompleted
-
Karbala UniversityCompleted
-
University Hospital ErlangenCompletedVascular Diseases | Vascular Malformations | Venous Malformation | Vascular Malformation PeripheralGermany
-
Seçil YavaşCompletedMaternal Hypotension Associated With Spinal Anesthesia During Cesarean SectionTurkey (Türkiye)
-
Hamilton Health Sciences CorporationMcMaster University; BSN Medical IncCompleted
-
University of RostockCompletedKnee Pain SwellingGermany
-
Belarusian State Medical UniversityCompleted
-
University of Sao PauloFundação de Amparo à Pesquisa do Estado de São PauloCompletedObstructive Sleep Apnea | Renal Failure Chronic Requiring DialysisBrazil